After finishing at $28.97 in the prior trading day, Omega Healthcare Investors Inc. (NYSE: OHI) closed at $28.48, down -1.69%. In other words, the price has decreased by -$0.49 from its previous closing price. On the day, 1430154 shares were traded. OHI stock price reached its highest trading level at $28.97 during the session, while it also had its lowest trading level at $28.43.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Our goal is to gain a better understanding of OHI by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.51 whereas as Long-Term Debt/Eq ratio is at 1.51.
Upgrades & Downgrades
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OHI now has a Market Capitalization of 6.22B and an Enterprise Value of 11.21B. As of this moment, Omega’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.36, and their Forward P/E ratio for the next fiscal year is 21.14. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.90 while its Price-to-Book (P/B) ratio in mrq is 1.91. Its current Enterprise Value per Revenue stands at 13.23 whereas that against EBITDA is 13.33.
Stock Price History:
Over the past 52 weeks, OHI has reached a high of $33.34, while it has fallen to a 52-week low of $25.61. The 50-Day Moving Average of the stock is 27.69, while the 200-Day Moving Average is calculated to be 29.37.
The stock has traded on average 2.00M shares per day over the past 3-months and 1.45M shares per day over the last 10 days, according to various share statistics. A total of 234.95M shares are outstanding, with a floating share count of 233.26M. Insiders hold about 0.30% of the company’s shares, while institutions hold 66.60% stake in the company. Shares short for OHI as of Apr 27, 2023 were 20.74M with a Short Ratio of 20.74M, compared to 21.77M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 8.85% and a Short% of Float of 12.16%.
Dividends & Splits
In the trailing 12 months, OHI’s forward annual dividend rate was 2.68, compared to 2.68 this year. Against a Trailing Annual Dividend Yield of 9.25%, it implies a Forward Annual Dividend Yield of 9.25%. The stock’s 5-year Average Dividend Yield is 8.15.
Its stock is currently analyzed by 4 different market analysts. On average, analysts expect EPS of $0.3 for the current quarter, with a high estimate of $0.31 and a low estimate of $0.29, while EPS last year was $0.38. The consensus estimate for the next quarter is $0.32, with high estimates of $0.34 and low estimates of $0.3.
Analysts are recommending an EPS of between $1.15 and $1.05 for the fiscal current year, implying an average EPS of $1.1. EPS for the following year is $1.35, with 6 analysts recommending between $1.4 and $1.27.
4 analysts predict $236.39M in revenue for the current quarter. It ranges from a high estimate of $238.32M to a low estimate of $233.42M. As of the current estimate, Omega Healthcare Investors Inc.’s year-ago sales were $244.65M, an estimated decrease of -3.40% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $243.3M, a decrease of -1.60% over than the figure of -$3.40% in the same quarter last year. There is a high estimate of $246.66M for the next quarter, whereas the lowest estimate is $240.6M.
A total of 7 analysts have provided revenue estimates for OHI’s current fiscal year. The highest revenue estimate was $951.47M, while the lowest revenue estimate was $750.63M, resulting in an average revenue estimate of $888.28M. In the same quarter a year ago, actual revenue was $878.24M, up 1.10% from the average estimate. Based on 8 analysts’ estimates, the company’s revenue will be $945.01M in the next fiscal year. The high estimate is $1.03B and the low estimate is $764.86M. The average revenue growth estimate for next year is up 6.40% from the average revenue estimate for this year.